| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | Jun 2, 2025 | Nautilus Biotechnology, Inc. | CFO | Buy | 91.3 | +15,000 | 22.06% | ✗ | $11.5K |
| Aug 19, 2022 | Aug 22, 2022 | Nautilus Biotechnology, Inc. | CFO | Buy | 91.3 | +17,500 | 44.59% | ✗ | $40.2K |
| Jun 27, 2022 | Jun 28, 2022 | Nautilus Biotechnology, Inc. | CFO | Buy | 91.3 | +5,500 | 16.30% | ✗ | $15.1K |
| Nov 24, 2021 | Nov 24, 2021 | Nautilus Biotechnology, Inc. | CFO | Buy | 95.0 | +15,000 | 85.71% | ✗ | $68.6K |
| Aug 12, 2021 | Aug 16, 2021 | Nautilus Biotechnology, Inc. | CFO | Buy | 95.0 | +17,500 | 100.00% | ✗ | $134.9K |